Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06337825 · ClinicalTrials.gov registry record
Object Assessment of Improvement in Non-Specific Symptoms After Parathyroidectomy for Primary Hyperparathyroidism
A clinical trial of Primary Hyperparathyroidism and Multinodular Goiter, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 45
- Enrollment target
- 1
- Study location
NCT06337825 is a study of Primary Hyperparathyroidism and Multinodular Goiter that has completed, run by The Cleveland Clinic. The registered enrollment target is 45 participants, below the 745-participant average among 7 other Primary Hyperparathyroidism trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06337825, a study of Primary Hyperparathyroidism and Multinodular Goiter, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
Wearable electronic devices are becoming more prevalent in daily life, as they offer real time information on physiological parameters such as heart rate, activity level, oxygenation, and sleep patterns for their users. These wearable electronic devices are easy to install and offer no major risk or discomfort to the user. Implementation of these technologies into medicine has exponentially grown in the past decade with supporting evidence for their use in cardiovascular disease and sleep medicine. The investigators believe that these devices will be able to capture the changes associated with improvement in non-specific symptoms that have not been previously demonstrated.
Conditions Studied
Interventions
- BEHAVIORAL Activity Tracker (Fitbit)
- DIAGNOSTIC_TEST HbA1C
- BEHAVIORAL The PROMPT Questionnaire
Study Locations (1)
Ohio
- The Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2022-07-19 |
| Est. Completion | 2024-06-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06337825
The ClinicalTrials.gov registry entry for NCT06337825 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 745-participant average among 7 other Primary Hyperparathyroidism trials with a reported enrollment target (94% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Primary Hyperparathyroidism appearing as the primary indexed condition, and to 3 interventions - of which Activity Tracker (Fitbit) is the first listed.
NCT06337825 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06337825 about?
NCT06337825 is a clinical study titled "Object Assessment of Improvement in Non-Specific Symptoms After Parathyroidectomy for Primary Hyperparathyroidism". Wearable electronic devices are becoming more prevalent in daily life, as they offer real time information on physiological parameters such as heart rate, activity level, oxygenation, and sleep patterns for their users. These wearable electronic devices are easy to install and offer no major risk or...
What is the current status of trial NCT06337825?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2022-07-19. Estimated completion is 2024-06-29.
What conditions does trial NCT06337825 study?
This clinical trial studies the following conditions: Primary Hyperparathyroidism, Multinodular Goiter.
What interventions are being tested in trial NCT06337825?
The interventions under investigation include: Activity Tracker (Fitbit) (BEHAVIORAL), HbA1C (DIAGNOSTIC_TEST), The PROMPT Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT06337825?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06337825 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Hyperparathyroidism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity
RECRUITING · Phase 4
-
Parathyroid Tumor Clonal Status
RECRUITING
-
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
RECRUITING
-
Natural History Study of Parathyroid Disorders
RECRUITING
-
Glycemic Control, Type II Diabetes, Parathyroidectomy
ACTIVE NOT RECRUITING
-
Circulating miRNA in Primary Hyperparathyroidism
COMPLETED
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.